155 results on '"Abraham, William T."'
Search Results
2. Abstract 13402: Outcomes of Cardiac Resynchronization Therapy in Ischemic versus Non-Ischemic Cardiomyopathy: A Patient-Level Meta-Analysis of 7 Randomized Clinical Trials
3. Abstract 12936: Quality of Life Assessments as Inclusion Criteria in Heart Failure Clinical Trials
4. Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
5. Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
6. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score–Matched Comparison
7. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
8. Abstract 9795: The Association Between Albumin and Outcomes in Heart Failure and Secondary Mitral Regurgitation: Insights From the COAPT Trial
9. Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials
10. Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype
11. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial
12. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study
13. Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure: DRI2P2S
14. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial
15. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
16. Abstract 18347: Prognostic Significance of Activation Delay by Cross Correlation Analysis Using Tissue Doppler Imaging in Patients With Heart Failure and Narrow QRS Duration; an Echocardiography Guided Cardiac Resynchronization Therapy (Echo-CRT) Trial Substudy of Patients Not Randomized to CRT
17. Abstract 16367: Treatment With Insulin is Associated With Worse Outcome in Patients With Chronic Heart Failure and Diabetes
18. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy
19. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation
20. Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients—An Analysis From 5 Clinical Trials
21. The Davis Heart and Lung Research Institute: Building a Sustainable Platform for Translation
22. Remote haemodynamic‐guided care for patients with chronic heart failure: a meta‐analysis of completed trials
23. Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography
24. Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients With Chronic Heart Failure
25. Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT
26. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
27. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial
28. Center of excellence for mobile sensor data-to-knowledge (MD2K)
29. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics
30. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy
31. Financial strain, inflammatory factors, and haemoglobin A1c levels in African American women
32. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
33. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium
34. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium
35. Reduction in ventricular arrhythmias and mortality in the primaries: a real-life win–win for CRT-Ds?
36. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure
37. Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients
38. Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
39. Trials of implantable monitoring devices in heart failure: which design is optimal?
40. Continuously adjusting CRT therapy: clinical impact of adaptive cardiac resynchronization therapy
41. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
42. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
43. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
44. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials
45. Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE
46. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
47. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
48. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting
49. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors
50. An Implantable Left Atrial Pressure Sensor Lead Designed for Percutaneous Extraction Using Standard Techniques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.